4 Marijuana Stocks That May Grow Your Portfolio

The global legal marijuana market is forecast to reach USD $146.4 billion by 2025, according to a report by Grand View Research. This growth can be contributed to the rising adoption of marijuana in several medical applications as well as the increased legalization seen around the world. The industry continues to show strength while the sentiment surrounding the stocks of the sector remains positive.

marijuanastocks.jpg

The North American legal marijuana market alone hit $12 billion last year, and analysts forecast that the market will reach $25.5 billion by 2021, according to a report by Cannabis Business Plan.  As the marijuana sector continues to generate growth, investors continue to place their bets on marijuana stocks.

Next Green Wave Holdings (NXGWF) (NGW.CN) announced that it, together with its US subsidiary Crossgate Capital US Holdings Corp. have signed a definitive agreement to acquire 100% of California-based SDC Ventures, LLC. The total value of this transaction is $20.6 million in cash, shares and performance shares to be earned over the next three years.  SDC a premium cannabis consumer products goods, manufacturing and extraction leader, with 8 leading cannabis brands, 45 CBD and THC products and a large network of retail and online sales channels including 700 Zumiez stores which compliments Next Green Wave’s current distribution opportunities.

“The SDC team shares our vision and provides expertise that is synergistic to that of Next Green Wave – to be the number 1 cannabis consumer products goods company in California,” stated Leigh Hughes, CEO. “Not only does this acquisition give us an array of premium brands associated with key world-renowned influencers to penetrate global markets, it also gives us increased distribution with revenues from sales, along with direct to consumer reach, relationships and specialty extraction methods. Having the opportunity to market through strategic brand partners to millions of validated and loyal followers is a big deal when marketing consumer products.”

This news followed the announcement of being granted Conditional Use Permits for nursery and both non-volatile and volatile extraction operations for its 3,240 ft² indoor facility by the City of Coalinga, CA as well as approval for the facility site design allowing for construction preparations to begin. This will enable Next Green Wave to accelerate its seed and seedling production program for its own yield and sales to licensed commercial growers and resellers. Furthermore, the facility will help advance innovative tissue culture research and the development of new high-quality cannabis strains using Intrexon’s (XON) Botticelli™ platform, allowing Next Green Wave to produce and sell seeds or clones that have standardized plant attributes and are pathogen and pesticide free.

Aurora Cannabis Inc (ACB) announced that it has appointed Nelson Peltz as a Strategic Advisor. Mr. Peltz and Aurora will work collaboratively and strategically to explore potential partnerships that would be the optimal strategic fit for successful entry into each of Aurora’s contemplated market segments and advise on the company’s global expansion strategy.

“Nelson is a globally recognized business visionary with a strong track record of constructive engagement to generate accelerated, profitable growth and shareholder value across many industry verticals that are of great interest to us,” said Terry Booth. “Like us, Nelson also takes a long-term view of value creation to benefit all stakeholders. We look forward to working with Nelson to further extend our global cannabis industry leadership by aligning Aurora with each of the major market segments cannabis is set to impact.”

Earlier this week, Aurora announced that it has commenced sales of cannabis oils to German pharmacies following receipt of all necessary approvals from the Canadian and German regulatory authorities. Pedanios 5/1 drops have become the first extract derived oil product compliant with the German monograph for in-pharmacy preparation. Neil Belot, Aurora’s Chief Global Business Development Officer, commented, “having established early mover advantage in selling cannabis oils in Germany, we are exceptionally positioned to extend our market leadership and accelerate the growth of our European operations”

Choom™ (CHOO.CN) (CHOOF) announced that it is entering the United States market, starting with the state of New Jersey, through its wholly owned US subsidiary, Choom Holdings USA Inc., has signed a letter of intent  to purchase an equity interest in a New Jersey based medical retail dispensary applicant in New Jersey’s upcoming Request of Applications that also intends to enter into recreational cannabis retail upon legalization, which is anticipated in 2020.

“This is our first step into the United States, and we are very excited for our partnership with this experienced group to have the Choom Brands in New Jersey.” states Chris Bogart, President & CEO.  “New Jersey is home to over 9 million people currently being served by only 12 cannabis operators in its medical program. New Jersey is an exceptional market to expand the Choom Brands.  We are very impressed with the progress they have achieved to date, and with our expertise in cannabis retail, we are confident we can help them successfully operate in the New Jersey market.”

Choom recently provided an update on its retail development strategy as an emerging consumer cannabis company that has secured one of the largest retail networks in Canada, as well as a $27 million-dollar investment from Aurora Cannabis (ACB). Choom has completed the buildouts of 17 retail locations across Western Canada and has 8 additional retail locations currently under construction.

HEXO Corp (HEXO) and Newstrike Brands Ltd. (TSX-V: HIP) annouced that they have entered into a definitive arrangement agreement under which HEXO will acquire all of Newstrike’s issued and outstanding common shares in an all-share transaction valued at approximately C$263 million.

Under the terms of the Arrangement Agreement, Newstrike shareholders will receive 0.06332 of a HEXO common share in exchange for each Newstrike common share held. The transaction has been unanimously approved by the board of directors of each of HEXO and Newstrike, and Newstrike’s board of directors recommends that its shareholders vote in favor of the Transaction.

“We’re thrilled to welcome the Newstrike team into the HEXO family.  Jay Wilgar (CEO of Newstrike) and his team have built incredible relationships, including teaming up with The Tragically Hip, and they share HEXO’s vision of bringing exceptional branded cannabis experiences to adults everywhere,” said Sebastien St-Louis, CEO and co-founder of HEXO. “With Newstrike, we’re adding talented employees and infrastructure to take HEXO to the next level on our journey to become one of the largest cannabis companies in the world. We’re extremely proud of our record of execution, and today are committing to achieving over $400 million in net revenue in 2020.”

marijuanastockstowatch.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between Midam and Next Green Wave (NGW), Midam has been paid $150,000 from Next Green Wave (NGW) for a period from October 1, 2018 to November 8, 2018. Midam has been compensated an additional $100,000 and has extended its period of coverage to December 8, 2018. Midam has been compensated an additional $75,000 and has extended its period of coverage to January 8, 2019. Midam has been compensated an additional $50,000 and has extended its period of coverage to February 8, 2019. Midam has been compensated an additional $100,000 and has extended its period of coverage to April 12, 2019. Midam may buy or sell additional shares of (NGW) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Next Green Wave. Click here For Full Disclaimer.

3 Marijuana Stocks To Watch This Week

The marijuana industry continues to show strength while the sentiment surrounding marijuana stocks remains very positive this year, possibly demonstrating even more signs of growth than seen in previous years. The global legal marijuana market is forecast to reach USD $146.4 billion by 2025, according to a report by Grand View Research. This growth can be contributed to the rising adoption of marijuana in several medical applications as well as the increased legalization seen around the world.

cannabisstocks.jpg

As marijuana continues to generate a more favorable opinion among the masses, investors looking for potential opportunities may benefit from keeping tabs on this rapidly growing industry.  For those that may be weary of a pure-play positions in marijuana stocks, there are companies that hold positions in traditional industries, while also working to expand a portion of their business to include the budding marijuana industry.

Premier Health Group, Inc. (PHGRF) (PHGI) announced its expansion plans to formally enter the cannabis clinic space and has been in discussions with Canadian ACMPR-Licensed Producers in order to partner with a, or multiple, Licensed Producers.

“We are currently working on a partnership model to hard code the decision-making process into the Electronic Medical Records (EMR),” said Dr. Essam Hamza, CEO. “There has been a critical gap between the patient’s need for medical cannabis and the doctor’s knowledge and comfort level in prescribing it. At Premier we understand the frustration felt from both the patient and the doctor and are integrating what we think is a revolutionary process. This new tool will allow us to provide a much-needed service to the 287 clinics and almost 3 million patients in our ecosystem.”

Most recently, Premier Health announced the launch of a technology enabled mental health initiative which will focus on providing app enabled mental health counselling for patients in urban and remote populations as well as growing its full-time development team at Cloud Practice by hiring 3 Web Software Developers and 1 User Interface/User Experience Designer to support the build out of its patient centric platform and mobile app – a beta version of which will be available by end of Q2.

The company is also in the process of closing on two operating pharmacies in Metro Vancouver and has entered into a strategic partnership with a major online healthcare company in China, 360 Health enabling the Premier’s healthcare team to connect with patients virtually in China to provide second opinion services.

Arcadia Biosciences (RKDA) announced that it has been granted an Industrial Hemp Pilot Program License by Hawaii’s Department of Agriculture. The license allows for the cultivation of industrial hemp in Hawaii for the purposes of agricultural and academic research. Hemp and hemp products produced under the program may be commercially sold. With this license, Hawaii becomes the first state where Arcadia Specialty Genomics will commence its research and cultivation of hemp, planting on ten acres of recently-leased land next month.

“With the explosive market growth projected in the industrial hemp and derivative markets, growers will need the very best hemp strains to meet demand, minimize waste, and ensure consistent quality. As the only company working in the cannabis industry with proven track record of improving plants and commercializing food ingredients from agricultural products using non-GM techniques, we’re ideally positioned to help hemp growers and end-users benefit from better hemp strains,” said Matt Plavan President of Arcadia Specialty Genomics.

This news followed last week’s launch of the company’s new division Arcadia Specialty Genomics, a first-of-its-kind strategic business unit to the optimization and standardization of cannabis plant content, quality, climate resiliency and yield to solely focus on the hemp market.

Medigus Ltd. (MDGS) announced that it has entered into a binding memorandum of understanding with Linkury Ltd., a wholly owned subsidiary of Algomizer Ltd., a leading company in the field of online advertising, to establish an e-commerce program for cannabidiol (CBD) products.

The agreement entails the two companies will invest in setting up an Internet platform, where Internet marketing, the establishment of an e-commerce platform and video sites will be carried out by Linkury, and the manufacturing, operation, and regulation related to the CBD products will be carried out by Meidgus. The companies will jointly invest up to $500,000 in the venture for infrastructure and marketing and will own it in equal parts. Furthermore, the two companies will explore entering into a definitive agreement and the formation of an international advertisement company, which will carry out the joint venture.

This is Medigus’ first investment in industry, following the announcement in mid-February of its intent to enter the CBD and medical cannabis markets. This venture is in accordance with the strategy of the company’s management and board of directors to bring value to the company and its shareholders, according to the company.

marijuanastocks.jpg


This blog is an affiliate of MIDAM VENTURES LLC. Pursuant to an agreement between Midam and Premier Health Group Inc., Midam was hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. Midam were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). Midam owns zero shares of Premier Health Group Inc., which Midam purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 Midam plans to sell the “500,000” shares of Premier Health Group Inc. that Midam holds currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Midam may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full Midam disclaimer.

3 Marijuana Stocks That Should Be On Your Watch-List

The marijuana industry continues to dominate media headlines this year, which in return is sparking increased investor interest in marijuana stocks.  According to the investment firm Cowen & Co., the marijuana industry is forecast to generate $75 billion in sales by 2030. This represents a significant increase from the previous a forecast of $50 billion by 2026.

cannabisstocks.jpg

Some of the key drivers of this growth can be contributed to the passing of major legislation, the public’s increased favorability of marijuana and spike seen of companies conducting business in the space. As marijuana continues to harvest a more favorable opinion among the public and investors, there are several marijuana stocks to watch as the industry continues to grow.

Premier Health Group, Inc. (PHGRF) (PHGI) announced as a part of its expansion plans, it is now formally entering the cannabis clinic space. Premier Health has been in discussions with a short list of Canadian Licensed Producers under the ACMPR in order to partner with a, or multiple, Licensed Producers to provide doctor and patient education at the clinic level and anticipates providing additional updates on its expansion later in Q1 2019. The company’s recent acquisition of Cloud Practice has provided the company with an underlying platform to help empower and streamline patient-doctor interaction.

“We are currently working on a partnership model to hard code the decision-making process into the Electronic Medical Records (EMR),” said Dr. Essam Hamza, CEO. “There has been a critical gap between the patient’s need for medical cannabis and the doctor’s knowledge and comfort level in prescribing it. At Premier we understand the frustration felt from both the patient and the doctor and are integrating what we think is a revolutionary process. This new tool will allow us to provide a much-needed service to the 287 clinics and almost 3 million patients in our ecosystem.”

The company is also moving forward with a binding LOI to acquire two cash flow positive Vancouver pharmacies and anticipates the acquisition to close in or about Q2 2019 and recently entered into a strategic partnership with China’s 360 Health, a healthcare subsidiary of 360 Security Technology.

Canopy Growth Corporation (CGC) (WEED) announced that it intends to increase its total investment in Canopy Rivers Inc. (RIV.V) by CA$30 million. The investment will be made through a private placement of subordinated voting shares in the capital of Canopy Rivers concurrent with Canopy Rivers bought deal offering of Subordinate Voting Shares for gross proceeds of approximately $55 million and is expected to close on or about February 27, 2019.

“The advantage of a strengthened Canopy Rivers/Canopy Growth relationship is that it accelerates and derisks execution for invested companies,” said Bruce Linton , Founder and Co-CEO. “The strength of the Canopy Rivers team, coupled with their selective approach to business development and execution of strategic investments, creates value for shareholders and for Canopy Growth.”

The company also announced earlier this month several updates regarding the its progress in the growing European marijuana market. Specifically, Canopy provided updates related to the UK and Poland, where the company’s medically-focused business Spectrum Cannabis continues to build a sophisticated, pan-European cannabis production and distribution network serving the needs of physicians and their patients throughout the continent.

Aurora Cannabis Inc (ACB)  announced that its extraction technology partner, Radient Technologies, has received its Standard Processing License from Health Canada earlier this week. In addition to the granting of the licensure, Radient announced the appointment of Aurora’s COO Allan Cleiren to its Board of Directors.

Denis Taschuk, CEO of Radient, commented, “our partnership with Aurora has been instrumental these past two years towards achieving this milestone. With our license granted, operations at our commissioned Edmonton I facility are now commencing. We are scaling up our operations further with the construction of our Edmonton II and III facilities, and we look forward to executing on our partnership with Aurora on a global scale.”

Aurora also recently announced the closing its previously announced offering of 5.5% convertible senior notes due 2024 for gross proceeds of $345 million. In a statement, the company said it planned to use the cash to expand in Canada and abroad, among other things. Investors will receive 138.37 shares for every $1,000 of debt, which is equivalent to a conversion price of $7.23.

marijuanastocks.jpg


This blog is an affiliate of MIDAM VENTURES LLC. Pursuant to an agreement between Midam and Premier Health Group Inc., Midam was hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. Midam were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). Midam owns zero shares of Premier Health Group Inc., which Midam purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 Midam plans to sell the “500,000” shares of Premier Health Group Inc. that Midam holds currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Midam may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full Midam disclaimer.

 

3 Marijuana Stocks To Watch During January’s Rally

Over the past few years the marijuana industry has occupied media headlines, during the course of which players in the industry saw huge boosts in investor interest.  According to investment firm Cowen & Co., the marijuana industry is expected to generate $75 billion in sales by 2030. This represents a significant increase from a previous forecast of $50 billion by 2026, which may be due to the passing of last year’s historic legislation, which turn increased the popularity of the industry as well as marijuana stocks.

marijuana.JPG

As more variables fall into place, marijuana continues to harvest a more favorable public opinion, resulting in more and more investors interested in getting involved in the space.  With that being said, there are several marijuana stocks to watch as the industry continues to gain momentum.

Premier Health Group, Inc. (PHGRF) (PHGI)  announced, further to its mid-December press release of a binding LOI, the company has now signed now a Definitive Agreement to acquire all of the outstanding securities of Cloud Practice Inc., a national cloud-based medical records software application company. The combined Premier and Cloud Practice ecosystem consists of over 3,000,000 patients.

“We are very excited to have completed this acquisition and to have the experienced team at Cloud Practice join the team at Premier Health. With this acquisition, we now have a medical software company with national reach. Thus, enabling us to build on our patient centric technology platform that will integrate telemedicine, online booking and other premium services with our electronic medical records (EMR) system,” said Dr. Essam Hamza, CEO.

The company also signed a binding LOI to acquire a British Columbia-based pharmacy and anticipates the acquisition to close in Q1–19, while it continues to evaluate additional pharmacy acquisitions and/or partnerships.  Premier Health also provided an update on its expansion into the Cannabis clinic space, that it has been in discussion with ACMPR-Licensed Producers, other licensed medical cannabis companies and government officials to establish a framework and actively recruit additional physicians and a cannabis-focused physician.

New Age Beverages (NBEV) announced that it will hold an investor conference call on Wednesday, January 16, at 8:30 AM EST to provide a special business update on a new relationship and material opportunity.

At the end of December, the company announced that it had closed on the merger with Morinda Holdings, Inc., a Utah-based healthy beverages and lifestyles company with operations in more than 60 countries.  The merger creates the 40th largest non-alcoholic beverage company in the world and provides New Age’s Health Sciences products and portfolio of CBD-infused beverages immediate access into 60 countries.

Brent Willis, Chief Executive Officer of New Age Beverages commented, “Since the announcement of the merger, we have been extremely busy. New Age continues to secure major national retail distribution on its key brands, and Morinda has been rapidly expanding its new Noni+Collagen brand globally. More cost synergies are emerging from the convergence teams and the countries are extremely enthusiastic about the potential of New Age’s current and impending brand portfolio through their system. Integration is already well on track, and we have a high degree of confidence in our plans for 2019.”

 

Canopy Growth Corporation (CGC) (WEED.TO) announced it has been granted a license by New York State to process and produce hemp. Canopy will establish within the Hemp Industrial Park large-scale production capabilities focused on hemp extraction and product manufacturing within the United States.

“Canopy Growth was founded to drive innovation within the cannabis and hemp industries. In New York we see an opportunity to create products that improve people’s lives,” said Bruce Linton, Chairman and Co-CEO. “In the process, we will create jobs in an exciting, highly profitable new industry. I applaud the political leadership at the federal and state level that has allowed today’s announcement to become reality.”

Canopy recently provided an update regarding its hemp operations as it prepares for US market entry, stating that its hemp division has harvested 190 million sq. ft. or 4,500 acres of cannabidiol (CBD)-rich hemp genetics in Saskatchewan and it has prepared broad product offerings specific to CBD across multiple verticals and will be launching brands and products in the first half of 2019.

cannabisstocks.jpg


This Blog is an affiliate of Midam Ventures LLC. Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. MIDAM was hired for a period from 10/1/2018–4/1/2019 to publicly disseminate information about Premier Health Group Inc. Midam was paid $100,000 (CASH) & “500,000” shares of restricted common shares, they own zero shares that were purchased in the open market. Once the (6) six-month restriction is complete on 4/1/2018, Midam plans to sell the “500,000” shares of Premier Health Group Inc. that they hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Midam may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full Midam disclaimer.

 

Marijuana Stocks On Track For Growth in 2019

Last year, the cannabis industry gained major validation as major milestones strengthened the growth of the cannabis sector around the world. Specifically, in North America, with Canada legalizing recreational pot and a handful of U.S. states giving the green light to cannabis use in some capacity and the passing of the US Farm Bill, a more favorable opinion towards marijuana has surfaced, resulting in increased investor interest in the sector.

marijuanastocks.jpg

“We expect continued growth in newly established U.S. states, and more robust growth in Canada as more supply comes online and new form factors hit the market,” Cowen analyst Vivien Azer wrote Tuesday.

The budding cannabis sector has shown exciting promise in terms of opportunities for investors looking to marijuana stocks, and is expected to continue full speed ahead in the coming year.  With the cannabis industry forecast to hit $146.4 billion by 2025, according to a new report by Grand View Research, Inc, there are several marijuana stocks to watch this year.

Premier Health Group, Inc. (PHGRF) (PHGI)  announced signing a binding LOI to acquire all the outstanding securities of a national cloud-based medical records software application company, Cloud Practice Inc., whose products ClinicAid, MyHealthAccess and Juno EMR are used by nearly 300 clinics and more than 3,000 licensed practitioners.

Dr. Essam Hamza, CEO “Cloud Practice already has a tremendous standalone and growing business serving thousands of clinicians and millions of patients. The collective ecosystem of over 3,000,000 patients creates an opportunity to become a key player.”

Premier also provided an update on its expansion into the Cannabis clinic space, that it has been in discussion with ACMPR-Licensed Producers, other licensed medical cannabis companies and government officials to establish a framework and actively recruit additional physicians.  The company has also signed a binding LOI to acquire a British Columbia based pharmacy and anticipates the acquisition to close in Q1–19 as it continues to evaluate additional pharmacy acquisitions and/or partnerships.

Premier Health entered the primary care clinic and healthcare technology business via the HealthVue transaction, obtaining access to a group of four Greater Vancouver-based fully integrated medical clinics with a 10-year history, 22 health care professionals and over 100,000 active patients.

Canopy Growth Corporation (CGC) (WEED.TO) Piper Jaffray initiated coverage today with an overweight rating and $40 price target. The company’s average rating among analysts is a buy, with an average price target of $61.

Canopy provided an update regarding its hemp operations as it prepares for US market entry. The company stated that its hemp division has harvested 190 million sq. ft. or 4,500 acres of cannabidiol (CBD)-rich hemp genetics in Saskatchewan. Once extracted, Canopy anticipates a yield of approximately 7,000 kilograms of hemp-derived CBD annually. The company also announced that it has prepared broad product offerings specific to CBD across multiple verticals and will be launching brands and products in the first half of 2019.

Bruce Linton, Chairman and Co-CEO, Canopy Growth, said, “Canopy has been preparing for and investing in this opportunity for several years now, through strategic acquisitions, infrastructure expansion, and extensive internal research and development. With the door now open, we are moving fast to bring our considerable resources to establish the same market leadership position internationally that we have earned in the Canadian cannabis market.”

Aphria Inc. (APHA) announced that it had completed its previously announced acquisition of CC Pharma GmbH, a leading distributor of pharmaceutical products to over 13,000 German pharmacies and throughout Europe.

“As one of the most promising medical cannabis markets in the world, Germany is a top strategic priority for Aphria. With today’s acquisition of CC Pharma, Aphria is creating a German and ultimately pan-European platform that brings together demand, supply and distribution.” said Vic Neufeld, CEO. “We’re excited to welcome the CC Pharma team and the pharmacists they serve to the Aphria family.”

The company also annouced that it has completed its first shipment of medical cannabis to Canadian retail pharmacy chain Shoppers Drug Mart and patients will be able to access the medical cannabis products through Shoppers Drug Mart’s e-commerce site.

Aphria will release its second quarter results for 2019 on January 11, 2019 at 7:00am ET, through SEDAR and the company’s website.   Aphria executives will then host a conference call to discuss these results at 9:00am ET.

marijuana.jpg




This Blog is an affiliate of Midam Ventures LLC. Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. MIDAM was hired for a period from 10/1/2018–4/1/2019 to publicly disseminate information about Premier Health Group Inc. Midam was paid $100,000 (CASH) & “500,000” shares of restricted common shares, they own zero shares that were purchased in the open market. Once the (6) six-month restriction is complete on 4/1/2018, Midam plans to sell the “500,000” shares of Premier Health Group Inc. that they hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Midam may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full Midam disclaimer.

3 Marijuana Stocks That Could Rally Into Next Year

North America is by far the leader of the cannabis industry, as it is not only the fastest growing region but also boasts the largest market share. This year, Canada became the first G7 nation to legalize adult-use recreational cannabis and the United States saw several additional states legalize one form or another of cannabis as well as hemp and hemp-derived CBD, thanks to the 2018 Farm Bill.

marijuanastocks.jpg

The two countries, together, command the global cannabis industry, which is predicted to reach $146.4 billion across the globe by 2025, with a compound annual growth rate of 34.6%, according to a Grand View Research report.  The increased legalization of cannabis along with the growing utilization in several medical applications are key factors for driving the growth of the industry.   As the cannabis industry continues to evolve, there are several marijuana stocks making headlines.

Premier Health Group, Inc. (PHGRF) (PHGI) announced signing a binding LOI to acquire all the outstanding securities of a cloud-based medical records software applications Cloud Practice Inc. Products include Juno EMR, ClinicAid, and MyHealthAccess.  The Juno EMR system alone is currently used by 287 clinics, over 3,000 licensed practitioners, 1,500 staff and 2,870,000 registered patients.

Dr. Essam Hamza, CEO “Cloud Practice already has a tremendous standalone and growing business serving thousands of clinicians and millions of patients. The collective ecosystem of over 3,000,000 patients creates an opportunity to become a key player.”

Premier also recently provided an update on its expansion into the Cannabis clinic space, that it has been in discussion with ACMPR-Licensed Producers, other licensed medical cannabis companies and government officials to establish a framework as well as actively recruiting additional physicians for existing clinics.  The company recently signed a binding Letter of Intent to acquire a British Columbia based pharmacy and expects the acquisition to close in Q1–19 while it continues to evaluate additional pharmacy acquisitions and/or partnerships.

Premier Health entered the primary care clinic and healthcare technology business via the HealthVue transaction, obtaining access to a group of four Greater Vancouver-based fully integrated medical clinics with a 10-year history, 22 health care professionals and over 100,000 active patients.

Aphria Inc. (APHA) Xanthic Biopharma Inc., which trades as Green Growth Brands (GGBXF), launched a takeover bid for Aphria. Green Growth said that its offer values Aphria at C$11 a share, or roughly C$2.1 billion, which is a 46% upside to Aphria’s closing price on December 24th.

Aphria responded to the unsolicited bid that it “significantly undervalues” the company as it is 23% below the company’s average share price. “While we appreciate GGB’s interest in the value we have created at Aphria and our significant growth prospects, their proposal falls short of rewarding our shareholders for participating in such a transaction,” commented Aphria’s Chairman Irwin Simon.

The company will release its second quarter results for 2019 on January 11, 2019 at 7:00am ET, through SEDAR and the company’s website.   Aphria executives will then host a conference call to discuss these results at 9:00am ET.

New Age Beverages (NBEV) announced the filing of a Form 8K – Acquisition or Disposition of Assets – with the U.S Securities and Exchange Commission on December 21, 2018.  The transactions contemplated by the merger agreement between New Age, Morinda Holdings, Inc., and New Age Health Sciences Holdings, Inc., a newly formed Utah corporation and wholly owned subsidiary of the company were completed. This was merged with and into Morinda and Morinda became a wholly-owned subsidiary of the Company which was merged with and into Morinda and Morinda became a wholly-owned subsidiary of the Company.

“This merger is excellent for both Morinda and New Age. Morinda adds New Age’s portfolio of healthy beverages to its network to drive further growth alongside its lead brand, Tahitian Noni. New Age adds significant scale, and infrastructure to accelerate growth, especially of its CBD-infused beverages and Health Sciences portfolio.” said Brent Willis, CEO commented

The merger creates the 40th largest non-alcoholic beverage company in the world and provides New Age’s Health Sciences products and portfolio of CBD-infused beverages immediate access into 60 countries.  New Age debuted its portfolio of CBD-infused beverages in October, which include relaxation tea’s, CBD-infused sparkling waters, and CBD-infused shots. The company intends to launch with major retailers and distributors throughout the US as soon as the newly passed Farm Bill is enacted in the new year.

cannabisstocks.jpg


This Blog is an affiliate of Midam Ventures LLC. Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. MIDAM was hired for a period from 10/1/2018–4/1/2019 to publicly disseminate information about Premier Health Group Inc. Midam was paid $100,000 (CASH) & “500,000” shares of restricted common shares, they own zero shares that were purchased in the open market. Once the (6) six-month restriction is complete on 4/1/2018, Midam plans to sell the “500,000” shares of Premier Health Group Inc. that they hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Midam may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full Midam disclaimer.

3 Marijuana Stocks Making Headlines This Week

As the year comes to an end, let’s reflect on the transformation that the marijuana industry has seen in 2018.  In North America alone, Canada took the cake and became the first industrialized country in the world to legalize adult-use recreational marijuana.  As for the US, ten states have now legalized adult-use while thirty-two have legalized marijuana for medicinal purposes.

cannabisstocks.jpg

Furthermore, the US Food and Drug Administration (FDA) gave the green light to the first cannabis-derived drug.  With the 2018 US Farm Bill pending final approval, Americans are about to see industrial hemp and hemp-derived cannabidiol (CBD) or CBD-based products soon become legal.

Marijuana stocks are taking center stage once again this week. The mix of premarket momentum and headlines are keeping this budding industry in the spotlight. As the sector continues to evolve with fresh potential seen from beverage and tobacco companies and even Big Pharma making their way into the space, investors continue to look for possible opportunities to grow their portfolios.

Premier Health Group, Inc. (PHGRF) (PHGI) announced that as a part of its technology platform, it has signed a binding LOI to acquire all the outstanding securities of a cloud-based medical records software applications Cloud Practice Inc. Products include Juno EMR, ClinicAid, and MyHealthAccess.  The Juno EMR system alone is currently used by 287 clinics, over 3,000 licensed practitioners, 1,500 staff and 2,870,000 registered patients.

Dr. Essam Hamza, CEO “Cloud Practice already has a tremendous standalone and growing business serving thousands of clinicians and millions of patients. The collective ecosystem of over 3,000,000 patients creates an opportunity to become a key player.”

Premier also recently provided an update on its expansion into the Cannabis clinic space, that it has been in discussion with ACMPR-Licensed Producers, other licensed medical cannabis companies and government officials to establish a framework and actively recruiting additional physicians for existing clinics.  The company has also signed a binding Letter of Intent to acquire a British Columbia based pharmacy and expects the acquisition to close in Q1–19 while it continues to evaluate additional pharmacy acquisitions and/or partnerships, including bricks and mortar locations and new retail opportunities.

Premier Health entered the primary care clinic and healthcare technology business via the HealthVue transaction, obtaining access to a group of four Greater Vancouver-based fully integrated medical clinics with a 10-year history, 22 health care professionals and over 100,000 active patients.

Tilray Inc. (TLRY) and Anheuser-Busch InBev (BUD), a world leading brewer announced a partnership to research non-alcohol beverages containing tetrahydrocannabinol (THC) and CBD. The partnership is limited to Canada and AB InBev’s participation will be through its subsidiary Labatt Breweries of Canada, with decisions regarding the commercialization of the beverages to be determined.

“We are delighted to be joining forces with a world-leading beverage company, AB InBev, to research how to create enjoyable cannabis beverage products. Tilray and AB InBev share a commitment to responsible product development and marketing, and we look forward to beginning our work on this important partnership as Tilray continues to pioneer the development of a professional, transparent, and well-regulated cannabis industry,” said Brendan Kennedy, CEO.

This news followed this week’s earlier announcement that its subsidiary, Tilray Canada Ltd, entered into a global framework agreement to collaborate with Sandoz AG, a global leader in generic pharmaceuticals and a part of Novartis (NVS) group, to increase availability of high-quality medical cannabis products across the world.  The agreement entails Sandoz may support the global commercialization of Tilray’s non-smokable medical cannabis products. The two companies may collaborate to co-brand certain non-smokable/non-combustible products and develop new innovative medical cannabis products.

New Age Beverages (NBEV) most recently announced the signing of a definitive agreement to acquire Morinda Holdings, Inc., a Utah-based healthy lifestyles and beverage company with operations in over 60 countries. The merger now creates the 40th largest non-alcoholic beverage company in the world and provides New Age’s Health Sciences products and portfolio of CBD-infused beverages immediate access into 60 countries, including in China and Japan.

New Age debuted its portfolio of CBD-infused beverages back in October which include relaxation tea’s, CBD-infused sparkling waters, and CBD-infused shots. The company intends to launch with major retailers and distributors throughout the US as soon as the 2018 Farm Bill is officially passed.

Brent Willis, CEO commented, “This merger is excellent for both Morinda and New Age. Morinda adds New Age’s portfolio of healthy beverages to its network to drive further growth alongside its lead brand, Tahitian Noni. New Age adds significant scale, and infrastructure to accelerate growth, especially of its CBD-infused beverages and Health Sciences portfolio. It is exciting to lead this company that has grown from $2 million to over $300 million in two-and-a-half years. We still feel like we are just getting started and are excited to work with our new associates from Morinda to build the world’s leading healthy beverage company.”

marijuanastocks.jpg

 


This Blog is an affiliate of Midam Ventures LLC. Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. MIDAM was hired for a period from 10/1/2018–4/1/2019 to publicly disseminate information about Premier Health Group Inc. Midam was paid $100,000 (CASH) & “500,000” shares of restricted common shares, they own zero shares that were purchased in the open market. Once the (6) six-month restriction is complete on 4/1/2018, Midam plans to sell the “500,000” shares of Premier Health Group Inc. that they hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Midam may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full Midam disclaimer.